OT - Statins may help treat Multiple Sclerosis, Alzheimer's and Ostoeporosis

[Sheri Nakken]

UNBELIEVABLE.......why do I keep saying that.
"safer than aspirin" - choke

it just keeps coming

just so you know more and more of your patients will be on these
Sheri
~~~~~~~~~~~~~~~~~~~~~~

http://www.medicalnewstoday.com/index.php?newsid=8307

Statins may help treat Multiple Sclerosis, Alzheimer?s and Ostoeporosis
14 May 2004
Statins, or cholesterol-lowering drugs, may be effective in treating MS
(multiple sclerosis), Alzheimer?s and osteoporosis, say some experts. Many
are calling statins the new ?aspirin?, but without so many side-effects
(aspirin, as well as being a pain-killer, has many other benefits).

The first clinical evidence has been produced by scientists at the Medical
University of S Carolina, USA, that statins can be effective in the
treatment of MS.

You can read about this new study in The Lancet (medical journal).

Thirty MS patients were given Zocor (simvastatin), 80 mg per day. Zocor is a
statin. Researchers reported that the patients experienced a 44% drop in
brain lesions within three months of starting treatment.

When areas of the brain experience inflammations they are called brain
lesions. Lesions tell us how the MS is progressing (becoming more severe).
The nerve cells of people with MS lose their insulating sheath. This leads
to muscle weakness, tiredness, bladder incontinence and problems with their
eyesight.

Currently, MS patients are given interferon injections. Interferon
injections are only partially effective. For patients to be able to switch
to swallowing statin pills, which are much cheaper and seemingly more
effective would be great news for them.

A large-scale controlled trial is going to take place soon with some of the
volunteers on statins and others on placebo. Professor Chris Polman, VU
Medical Center, Amsterdam, Netherlands, said that the trial should take
about two years to complete.

Timothy Vollmer and his team in South Carolina who carried out this new
study said that they had been encouraged by previous studies which indicated
that statins reversed paralysis in mice with MS.

Apart from being able to block an enzyme which helps the liver produce
cholesterol, statins seem to undermine the inflammatory processes as well.
Inflammations in the body are associated with higher risks of developing
many chronic diseases.

Scientists and doctors still have a long way to go, the team said. They have
to find out what the ideal dosage might be. They think the dosage for people
with MS will probably have to be higher than for people with clogged
arteries.

Professor Polman told existing MS patients not to switch to statins now and
drop their existing treatment. He said the use of statins without knowing
more about them could boomerang.

The temptation to go out and get statins in the UK will be higher. In the UK
statins will soon be available over the counter, without the need for a
prescription from a doctor.

WHAT IS MULTIPLE SCLEROSIS?

MS is thought to be an autoimmune disease that affects the central nervous
system (CNS). The CNS consists of the brain, spinal cord, and the optic
nerves. Surrounding and protecting the nerve fibers of the CNS is a fatty
tissue called myelin, which helps nerve fibers conduct electrical impulses.

In MS, myelin is lost in multiple areas, leaving scar tissue called
sclerosis. These damaged areas are also known as plaques or lesions.
Sometimes the nerve fiber itself is damaged or broken.

Myelin not only protects nerve fibers, but makes their job possible. When
myelin or the nerve fiber is destroyed or damaged, the ability of the nerves
to conduct electrical impulses to and from the brain is disrupted, and this
produces the various symptoms
(http://www.nationalmssociety.org/symptoms.asp) of MS.

People with MS can expect one of four clinical courses of disease, each of
which might be mild, moderate, or severe.

RELAPSING-REMITTING

Characteristics: People with this type of MS experience clearly defined
flare-ups (also called relapses, attacks, or exacerbations). These are
episodes of acute worsening of neurologic function. They are followed by
partial or complete recovery periods (remissions) free of disease
progression.
Frequency: Most common form of MS at time of initial diagnosis.
Approximately 85%.

PRIMARY-PROGRESSIVE

Characteristics: People with this type of MS experience a slow but nearly
continuous worsening of their disease from the onset, with no distinct
relapses or remissions. However, there are variations in rates of
progression over time, occasional plateaus, and temporary minor
improvements.
Frequency: Relatively rare. Approximately 10%.

SECONDARY-PROGRESSIVE

Characteristics: People with this type of MS experience an initial period of
relapsing-remitting disease, followed by a steadily worsening disease course
with or without occasional flare-ups, minor recoveries (remissions), or
plateaus.
Frequency: 50% of people with relapsing-remitting MS developed this form of
the disease within 10 years of their initial diagnosis, before introduction
of the ?disease-modifying? drugs. Long-term data are not yet available to
demonstrate if this is significantly delayed by treatment.

PROGRESSIVE-RELAPSING

Characteristics: People with this type of MS experience a steadily worsening
disease from the onset but also have clear acute flare-ups (attacks or
relapses), with or without recovery. In contrast to relapsing-remitting MS,
the periods between relapses are characterized by continuing disease
progression.
Frequency: Relatively rare. Approximately 5%.

--------------------------------------------------------------------
Sheri Nakken, R.N., MA, Classical Homeopath
Well Within & Earth Mysteries & Sacred Site Tours (worldwide)
Vaccination Information & Choice Network
http://www.nccn.net/~wwithin/vaccine.htm
http://www.nccn.net/~wwithin/homeo.htm
homeopathycures@tesco.net
ONLINE Introduction to Homeopathy Classes
ONLINE Introduction to Vaccine Dangers Classes
ANY INFO OBTAINED HERE NOT TO BE CONSTRUED AS MEDICAL
OR LEGAL ADVICE. THE DECISION TO VACCINATE IS YOURS AND YOURS ALONE
Voicemail US 530-740-0561 UK phone from US 011-44-1874-624-936